2026-23300NoticeWallet

NIH Revisits Its 1998 Rules for Monitoring Research Safety

Published Date: 11/17/2026

Notice

Summary

The NIH wants to update its 1998 rules to keep people safe and data accurate in all NIH-supported clinical research, not just clinical trials. They’re asking for public feedback by January 6, 2027, to make sure the new plan focuses on higher-risk studies and cuts red tape for lower-risk ones. This update affects researchers and aims to improve health discoveries without adding unnecessary costs or delays.

Analyzed Economic Effects

7 provisions identified: 3 benefits, 4 costs, 0 mixed.

All NIH Clinical Research Now Covered

NIH proposes to expand the 1998 data and safety monitoring rules from only clinical trials to all NIH-supported clinical research. This change would apply to studies funded in whole or in part by NIH, including intramural projects and extramural grants, contracts, and other funding agreements.

Noncompliance Can Affect Funding

If institutions fail to comply with the policy, NIH may use remedies including special award conditions, suspension, withholding, termination of funding, or other enforcement actions that can affect future funding decisions. These enforcement actions would be applied consistent with NIH Grants Policy and applicable federal procedures.

Must Have ICO‑Approved Monitoring Plan Before Starting

The draft requires a data and safety monitoring plan approved by the awarding NIH Institute, Center, or Office (ICO) before initiating any human subject activities. The NIH ICO must respond within 30 days after receiving a requested plan; if there is no response after 30 days, the plan is deemed approved.

Fewer Mandatory DSMBs for Large Trials

The draft would remove the blanket requirement to have a Data and Safety Monitoring Board (DSMB) for all phase 3 or multi-site clinical trials and instead allow study-specific, risk-based monitoring approaches. This change is intended to give investigators more flexibility and reduce administrative burden for some trials.

Reporting, Amendments, and Annual Review Required

Monitoring plan amendments must be reported and, when changes require prior approval under NIH rules, approved by the awarding NIH ICO; other amendments require summary reporting during regular reporting intervals. Routine monitoring reports should be reviewed at least annually by qualified personnel.

Monitoring Costs Can Be Included in Budgets

The draft confirms that costs for monitoring—such as study staff time and compensation for independent monitors—may be allowable items in the study budget. Investigators can budget for monitoring activities and independent monitor compensation under their grant or contract.

Supplemental Guidance and SI Tools May Be Provided

NIH may develop supplemental resources—such as guidance documents, templates, example plans in an approved format, and Super Intelligence (SI)-assisted reformatting tools—to help researchers implement risk-based monitoring and reduce burden. NIH is explicitly seeking input on what resources would be helpful.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Comments Due
11/17/2026
1/6/2027

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
National Institutes of Health
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register